Why Patient Diversity Is Key to Better Clinical Trial Outcomes
Beyond being a regulatory checkbox, patient diversity is a critical factor in developing safer, more effective medical treatments for everyone. When diversity is missing, the consequences are concrete and sometimes severe: Safety signals get missed. Adverse events that show up only in specific populations may go undetected until after a drug reaches the market. Efficacy […]
The Philippines as a Patient Recruitment Powerhouse
In recent years, the Philippines has evolved from a promising trial location to a strategic hub for global studies. With a large, English-speaking population investigators trained to international standards[1], and a growing network of accredited research sites, the country has the essential foundations for high-quality study execution, with the support of a transparent regulatory framework[2] […]
The Philippines: A Pivotal Destination for Global Clinical Trials
More global CROs and sponsors are tapping into Southeast Asia — but few realize the Philippines may be its best-kept secret. This rising trial destination delivers the speed, scale, and global-quality execution needed for today’s most important breakthroughs. Introducing our new eBook: We’ve created this resource to help clinical research professionals, sponsors, and CROs understand […]